Wegovy 0.5 mg: where this dose sits in your treatment plan

Step 1: the logic of starting low and moving up in stages

The Wegovy titration schedule exists because semaglutide affects gastric emptying and appetite signalling in ways the body needs time to adapt to. Jumping straight to a higher dose would mean more people stopping early due to nausea or vomiting, so the protocol builds in deliberate pauses.

The sequence runs: 0.25 mg for four weeks, then 0.5 mg for four weeks, then 1.0 mg, 1.7 mg, and finally 2.4 mg as the standard maintenance dose. The 0.25 mg period is pure adjustment, its job is settling your system, not producing weight loss. The 0.5 mg period continues that acclimatisation while beginning to exert a more meaningful effect on appetite.

Some people do notice a difference in hunger at 0.5 mg. Others find the real change comes later. Neither is wrong. What matters is that your prescriber is tracking how you are tolerating each stage before signing off on the next increase. If you have questions about the full Wegovy dose schedule and what to expect at each level, that page covers the whole picture.

Step 2: what to expect at 0.5 mg specifically

At 0.5 mg, the commonest experiences are the same GI-led side effects seen across the whole semaglutide range: nausea, loose stools, constipation, reflux, or a general sense of fullness after smaller amounts of food. These are dose-dependent, which means they often increase when you move from 0.25 mg to 0.5 mg and then ease again over the following one to two weeks as your body adapts.

Practical things that help at this stage: eating slowly, keeping portions moderate, staying well hydrated, and avoiding high-fat meals that slow digestion further. If symptoms are still significant after two weeks at 0.5 mg and are affecting your daily life, that is a conversation for your prescriber, not something to push through silently or manage by skipping injections.

Injection technique also matters more than people expect. Rotating sites between the abdomen, thigh and upper arm, and using a fresh needle each time, reduces localised reactions. For anyone new to the process, our Wegovy overview covers the basics of the injection itself in straightforward terms.

One thing our prescribers are asked regularly: can you stay at 0.5 mg longer than four weeks? Yes, if you and your prescriber agree. The schedule is a guide, not a strict deadline. Some people tolerate the step-up more comfortably with an extra few weeks, and that flexibility is clinically reasonable.

Step 3: knowing when 0.5 mg is working and when to move on

Wegovy's weight management effect builds across the full titration period. Expecting significant weight loss at 0.5 mg alone, within the first month at that level, sets an unrealistic benchmark, and can lead people to conclude the medicine is not working when it is simply not yet at the dose where the full effect is possible.

A more useful measure at this stage is tolerance. Are you completing each weekly injection? Is the nausea manageable? Are you able to follow the lifestyle guidance your prescriber has recommended? Those signs matter more than the scale reading during the lower doses. The STEP 1 trial published in the New England Journal of Medicine showed an average 15% weight reduction over 68 weeks at the 2.4 mg maintenance dose, that outcome comes from completing the whole course, not from any single early dose.

The question of what comes after 0.5 mg is also worth understanding in advance. Some people stay on 1.0 mg as a longer-term dose if they are responding well and tolerating it; others continue to 1.7 mg and then 2.4 mg, which you can read about on the Wegovy 2.5 mg page. There is now also a 7.2 mg maintenance dose, approved by the MHRA in 2026, for eligible adults requiring a higher level of treatment. If you want a clear sense of how the later doses compare, the 5 mg semaglutide dose context page places the higher end of the schedule in useful perspective.

Clinical review at every step: what this means in practice

A detail worth naming plainly: the dose escalation from 0.5 mg to 1.0 mg is not automatic. Under good clinical practice, each increase should follow a prescriber's review, checking that you have tolerated the current dose, that your weight trajectory is reasonable, and that there are no new contraindications.

At nume, every repeat order goes through a clinical re-review before dispatch. A real prescriber reads your updated responses; nothing is rubber-stamped. If you are approaching your next dose increase and are not sure how to frame that conversation, our FAQs cover common questions about progressing through treatment, including a breakdown of the different Wegovy mg strengths to help you understand where you are in the schedule. You can also reach the team through the contact page if something specific is on your mind.

For context on what the full private treatment journey involves, including what a transparent price actually covers, the treatment page is the clearest place to start. If you are still deciding whether Wegovy suits your situation or whether a different licensed option might be a better clinical fit, the weight loss overview sets out the options side by side.

The 0.5 mg dose is not where the story ends. It is where it properly begins. Check your eligibility and speak to our prescribers about what comes next.